|
|
Biomarker Prediction of Preeclampsia With Severe Features
|
SMFM Endorsed Partner Publication
|
ACOG |
2024 |
|
|
SMFM Special Statement: Prophylactic low-dose aspirin for preeclampsia prevention—quality metric ...
|
SMFM Statement
|
SMFM |
2023 |
|
|
Preeclampsia: a report and recommendations of the workshop of the Society for Maternal-Fetal Medi...
|
SMFM Special Report
|
SMFM |
2022 |
|
|
SMFM Statement: Antihypertensive therapy for mild chronic hypertension in pregnancy: The CHAP Trial
|
SMFM Statement
|
SMFM, Publications Committee |
2022 |
|
|
ACOG-SMFM Practice Advisory: Low-Dose Aspirin Use for the Prevention of Preeclampsia and Related ...
|
Joint Publication
|
ACOG and SMFM |
2021 |
|
|
Executive summary: Workshop on Preeclampsia, January 25–26, 2021, cosponsored by the Society for ...
|
SMFM Special Report
|
SMFM |
2021 |
|
|
SMFM Special Statement: Checklists for preeclampsia risk-factor screening to guide recommendation...
|
SMFM Statement
|
SMFM, CA Combs, D Montgomery |
2020 |
|
|
Joint Committee Opinion #743, Low-dose aspirin use during pregnancy
|
Joint Publication
|
ACOG Committee on Ob Practice and SMFM |
2018 |
|
|
SMFM White Paper: Pregnancy as a Window to Future Health
|
Internal Medicine & Medicine Subspecialists
OB-GYN, Sub-specialist, Certified Nurse Midwife and Laborist
|
Smith, G.N and Saade, G. for the SMFM Health Policy Committee |
2013 |
